No, Premenstrual Cravings Do Not Cause High Estrogen Levels—The Relationship is Reversed
The causality flows in the opposite direction: elevated estrogen levels during the luteal phase are associated with increased premenstrual food cravings, not the other way around. Cravings are a symptom that may result from hormonal fluctuations, particularly higher estradiol concentrations, rather than being a cause of hormonal changes.
The Evidence on Hormones and Cravings
Estrogen's Role in Premenstrual Cravings
The most robust evidence demonstrates that higher luteal phase estradiol levels correlate with more severe premenstrual symptoms, including food cravings 1. Women experience more intense PMS symptoms in menstrual cycles characterized by elevated luteal phase estradiol and progesterone concentrations 1. Specifically:
- High luteal phase estradiol is linked to increased adverse premenstrual symptoms and decreased positive mood 1
- The estradiol-leptin axis appears to be a key determinant of luteal phase cravings 2
- Women with higher estradiol and higher estradiol-to-leptin ratios report significantly more cravings for sweet and carbohydrate-rich foods 2
A 2021 study found that adolescent girls experiencing PMS had mean estrogen levels of 148.32 pg/ml compared to 98.00 pg/ml in those without PMS 3, further supporting that elevated estrogen associates with premenstrual symptoms rather than being caused by them.
Progesterone's Protective Effect
Interestingly, progesterone appears to have an inverse relationship with food cravings 4. The 2023 research using hierarchical modeling showed a significant dampening effect of mid-luteal progesterone on premenstrual food cravings (p=0.038), while estradiol showed no protective effect 4. This suggests progesterone may actually reduce craving intensity, contradicting older theories about progesterone deficiency causing PMS.
Understanding the Biological Direction
Why Cravings Cannot Cause Hormonal Changes
From a physiological standpoint, food cravings are a behavioral and neurological phenomenon that cannot directly alter ovarian hormone production. Estrogen and progesterone levels are primarily regulated by:
- The hypothalamic-pituitary-ovarian (HPO) axis
- Follicular development and corpus luteum function
- Feedback mechanisms involving FSH and LH 5
Food intake and cravings do not have direct regulatory control over these endocrine pathways in the acute premenstrual timeframe.
The Actual Mechanism
The relationship appears to work through these pathways:
- Hormonal fluctuations occur first: Estradiol rises during the luteal phase as part of normal menstrual physiology
- Estradiol interacts with appetite-regulating hormones: Particularly through the estradiol-leptin axis 2
- Neurobiological changes follow: These hormonal shifts affect brain reward pathways and craving centers
- Cravings manifest as symptoms: Women then experience increased desire for specific foods, particularly chocolate, sweets, and high-fat items 6, 7
Clinical Implications
Common Pitfalls to Avoid
- Do not interpret cravings as a sign of hormonal imbalance requiring treatment unless accompanied by other significant menstrual irregularities
- Recognize that cravings are a normal physiological response to hormonal fluctuations in many women 6
- Avoid attributing all premenstrual symptoms to progesterone deficiency, as evidence shows higher progesterone may actually be protective 4
What to Monitor
If a patient presents with concerns about premenstrual cravings:
- Assess for true menstrual cycle irregularities (cycles persistently >45 days or amenorrhea >3 months) that might indicate functional hypothalamic amenorrhea or PCOS 5, 8
- Screen for eating disorders, particularly if cravings are accompanied by restrictive eating patterns 5
- Evaluate for depression and anxiety, which commonly co-occur with PMS 8
- Consider the role of ultra-processed food consumption, which is significantly higher in women with PMS and may exacerbate symptoms 7
The evidence consistently shows that hormonal changes drive cravings, not vice versa, with inflammation potentially playing a mediating role 9.